drugset / Trial / NCT05466695

Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response

NCT05466695

Phase 0 Unknown 74 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

1- To evaluate the effect of using tadalafil 5mg/day or sildenafil 25mg/day in the treatment on these ratios and its clinical effect in erectile dysfunction patients.

Timeline

Start
2022-08-01
Primary completion
2023-07-01
Completion
2023-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg
Subject Tadalafil Small molecule 5 mg

Indications

No indication recorded.